These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1412529)

  • 1. Clinical expression of organophosphate-induced delayed polyneuropathy in rats.
    Moretto A; Capodicasa E; Lotti M
    Toxicol Lett; 1992 Oct; 63(1):97-102. PubMed ID: 1412529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organophosphate polyneuropathy in chicks.
    Peraica M; Capodicasa E; Moretto A; Lotti M
    Biochem Pharmacol; 1993 Jan; 45(1):131-5. PubMed ID: 8381002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylmethanesulfonyl fluoride elicits and intensifies the clinical expression of neuropathic insults.
    Moretto A; Bertolazzi M; Capodicasa E; Peraica M; Richardson RJ; Scapellato ML; Lotti M
    Arch Toxicol; 1992; 66(1):67-72. PubMed ID: 1316117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triphenylphosphite neuropathy in hens.
    Fioroni F; Moretto A; Lotti M
    Arch Toxicol; 1995; 69(10):705-11. PubMed ID: 8572929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of S-ethyl hexahydro-1H-azepine-1-carbothioate (molinate) on di-n-butyl dichlorovinyl phosphate (DBDCVP) neuropathy.
    Moretto A; Gardiman G; Panfilo S; Colle MA; Lock EA; Lotti M
    Toxicol Sci; 2001 Aug; 62(2):274-9. PubMed ID: 11452140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride.
    Lotti M; Caroldi S; Capodicasa E; Moretto A
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):234-41. PubMed ID: 2017753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
    Moretto A; Bertolazzi M; Lotti M
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro regional differential sensitivity of neuropathy target esterase to di-n-butyl-2,2-dichlorovinyl phosphate.
    Moretto A; Lotti M; Spencer PS
    Arch Toxicol; 1989; 63(6):469-73. PubMed ID: 2619560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks.
    Moretto A; Capodicasa E; Peraica M; Lotti M
    Biochem Pharmacol; 1991 May; 41(10):1497-504. PubMed ID: 2018554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organophosphate induced delayed polyneuropathy.
    Jokanovic M; Stukalov PV; Kosanovic M
    Curr Drug Targets CNS Neurol Disord; 2002 Dec; 1(6):593-602. PubMed ID: 12769600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
    Milatovic D; Moretto A; Osman KA; Lotti M
    Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated low doses of O-(2-chloro-2,3,3 trifluorocyclobutyl) O-ethyl S-propyl phosphorothioate (KBR-2822) do not cause neuropathy in hens.
    Jokanovic M; Moretto A; Lotti M
    Arch Toxicol; 1998; 72(2):93-6. PubMed ID: 9456080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organophosphate polyneuropathy and neuropathy target esterase: studies with methamidophos and its resolved optical isomers.
    Lotti M; Moretto A; Bertolazzi M; Peraica M; Fioroni F
    Arch Toxicol; 1995; 69(5):330-6. PubMed ID: 7654138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
    Sogorb MA; González-González I; Pamies D; Vilanova E
    Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of organophosphate polyneuropathy.
    Lotti M
    Crit Rev Toxicol; 1991; 21(6):465-87. PubMed ID: 1666291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
    Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy (OPIDP) induced by some organophosphorus esters.
    Johnson MK
    Chem Biol Interact; 1993 Jun; 87(1-3):339-46. PubMed ID: 8343991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous biochemical responses in tests of the delayed neuropathic potential of methamidophos (O,S-dimethyl phosphorothioamidate), its resolved isomers and of some higher O-alkyl homologues.
    Johnson MK; Vilanova E; Read DJ
    Arch Toxicol; 1991; 65(8):618-24. PubMed ID: 1660708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between isofenphos cholinergic toxicity and the development of polyneuropathy in hens and humans.
    Moretto A; Lotti M
    Arch Toxicol; 2002 Jun; 76(5-6):367-75. PubMed ID: 12107655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organophosphate polyneuropathy: pathogenesis and prevention.
    Lotti M; Becker CE; Aminoff MJ
    Neurology; 1984 May; 34(5):658-62. PubMed ID: 6324035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.